Cardiovascular risk in systemic lupus erythematosus—evidence of increased oxidative stress and dyslipidaemia
Identifieur interne : 002124 ( Main/Exploration ); précédent : 002123; suivant : 002125Cardiovascular risk in systemic lupus erythematosus—evidence of increased oxidative stress and dyslipidaemia
Auteurs : S. L. Nuttall ; S. Heaton [Royaume-Uni] ; M. K. Piper [Royaume-Uni] ; U. Martin ; C. Gordon [Royaume-Uni]Source :
- Rheumatology [ 1462-0324 ] ; 2003.
Abstract
Objectives. Systemic lupus erythematosus (SLE) is associated with severe and premature cardiovascular disease, which is not explained by traditional risk factors alone. This study aimed to investigate markers of oxidative stress, lipid metabolism and inflammation as potential cardiovascular risk factors in women with SLE. Methods. Venous blood samples were taken from 53 female Caucasian patients with SLE and from healthy age‐ and sex‐matched controls. Samples were analysed for markers of oxidative stress, lipid metabolism [including low‐density lipoprotein (LDL) subfraction profile] and C‐reactive protein (CRP). Results. Female SLE patients had an atherogenic lipid profile characterized by raised total cholesterol and triglycerides, and the presence of small, dense LDL subfractions compared with healthy controls. These changes were associated with increased oxidative damage and a moderately raised CRP. Conclusions. The results provide evidence for free radical and inflammatory activity in SLE and suggest potential targets to reduce the risk of cardiovascular disease in these patients.
Url:
DOI: 10.1093/rheumatology/keg212
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000810
- to stream Istex, to step Curation: 000810
- to stream Istex, to step Checkpoint: 000F60
- to stream Main, to step Merge: 002143
- to stream Main, to step Curation: 002124
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cardiovascular risk in systemic lupus erythematosus—evidence of increased oxidative stress and dyslipidaemia</title><author><name sortKey="Nuttall, S L" sort="Nuttall, S L" uniqKey="Nuttall S" first="S. L." last="Nuttall">S. L. Nuttall</name></author><author><name sortKey="Heaton, S" sort="Heaton, S" uniqKey="Heaton S" first="S." last="Heaton">S. Heaton</name></author><author><name sortKey="Piper, M K" sort="Piper, M K" uniqKey="Piper M" first="M. K." last="Piper">M. K. Piper</name></author><author><name sortKey="Martin, U" sort="Martin, U" uniqKey="Martin U" first="U." last="Martin">U. Martin</name></author><author><name sortKey="Gordon, C" sort="Gordon, C" uniqKey="Gordon C" first="C." last="Gordon">C. Gordon</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:18C9E05438EDE05FF96C0596197D0A1F5CF4CB7C</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1093/rheumatology/keg212</idno><idno type="url">https://api.istex.fr/ark:/67375/HXZ-RTX30K91-N/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000810</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000810</idno><idno type="wicri:Area/Istex/Curation">000810</idno><idno type="wicri:Area/Istex/Checkpoint">000F60</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000F60</idno><idno type="wicri:doubleKey">1462-0324:2003:Nuttall S:cardiovascular:risk:in</idno><idno type="wicri:Area/Main/Merge">002143</idno><idno type="wicri:Area/Main/Curation">002124</idno><idno type="wicri:Area/Main/Exploration">002124</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Cardiovascular risk in systemic lupus erythematosus—evidence of increased oxidative stress and dyslipidaemia</title><author><name sortKey="Nuttall, S L" sort="Nuttall, S L" uniqKey="Nuttall S" first="S. L." last="Nuttall">S. L. Nuttall</name><affiliation><wicri:noCountry code="no comma">Clinical Pharmacology and</wicri:noCountry></affiliation></author><author><name sortKey="Heaton, S" sort="Heaton, S" uniqKey="Heaton S" first="S." last="Heaton">S. Heaton</name><affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Rheumatology, University of Birmingham, Birmingham</wicri:regionArea><placeName><settlement type="city">Birmingham</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Midlands de l'Ouest</region></placeName><orgName type="university">Université de Birmingham</orgName></affiliation></author><author><name sortKey="Piper, M K" sort="Piper, M K" uniqKey="Piper M" first="M. K." last="Piper">M. K. Piper</name><affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Rheumatology, University of Birmingham, Birmingham</wicri:regionArea><placeName><settlement type="city">Birmingham</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Midlands de l'Ouest</region></placeName><orgName type="university">Université de Birmingham</orgName></affiliation></author><author><name sortKey="Martin, U" sort="Martin, U" uniqKey="Martin U" first="U." last="Martin">U. Martin</name><affiliation><wicri:noCountry code="no comma">Clinical Pharmacology and</wicri:noCountry></affiliation></author><author><name sortKey="Gordon, C" sort="Gordon, C" uniqKey="Gordon C" first="C." last="Gordon">C. Gordon</name><affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Rheumatology, University of Birmingham, Birmingham</wicri:regionArea><placeName><settlement type="city">Birmingham</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Midlands de l'Ouest</region></placeName><orgName type="university">Université de Birmingham</orgName></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Rheumatology</title><title level="j" type="abbrev">Rheumatology</title><idno type="ISSN">1462-0324</idno><idno type="eISSN">1462-0332</idno><imprint><publisher>Oxford University Press</publisher><date when="2003-06">2003</date><biblScope unit="vol">42</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="758">758</biblScope><biblScope unit="page" to="762">762</biblScope></imprint><idno type="ISSN">1462-0324</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1462-0324</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Objectives. Systemic lupus erythematosus (SLE) is associated with severe and premature cardiovascular disease, which is not explained by traditional risk factors alone. This study aimed to investigate markers of oxidative stress, lipid metabolism and inflammation as potential cardiovascular risk factors in women with SLE. Methods. Venous blood samples were taken from 53 female Caucasian patients with SLE and from healthy age‐ and sex‐matched controls. Samples were analysed for markers of oxidative stress, lipid metabolism [including low‐density lipoprotein (LDL) subfraction profile] and C‐reactive protein (CRP). Results. Female SLE patients had an atherogenic lipid profile characterized by raised total cholesterol and triglycerides, and the presence of small, dense LDL subfractions compared with healthy controls. These changes were associated with increased oxidative damage and a moderately raised CRP. Conclusions. The results provide evidence for free radical and inflammatory activity in SLE and suggest potential targets to reduce the risk of cardiovascular disease in these patients.</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Midlands de l'Ouest</li></region><settlement><li>Birmingham</li></settlement><orgName><li>Université de Birmingham</li></orgName></list><tree><noCountry><name sortKey="Martin, U" sort="Martin, U" uniqKey="Martin U" first="U." last="Martin">U. Martin</name><name sortKey="Nuttall, S L" sort="Nuttall, S L" uniqKey="Nuttall S" first="S. L." last="Nuttall">S. L. Nuttall</name></noCountry><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Heaton, S" sort="Heaton, S" uniqKey="Heaton S" first="S." last="Heaton">S. Heaton</name></region><name sortKey="Gordon, C" sort="Gordon, C" uniqKey="Gordon C" first="C." last="Gordon">C. Gordon</name><name sortKey="Piper, M K" sort="Piper, M K" uniqKey="Piper M" first="M. K." last="Piper">M. K. Piper</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002124 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002124 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:18C9E05438EDE05FF96C0596197D0A1F5CF4CB7C
|texte= Cardiovascular risk in systemic lupus erythematosus—evidence of increased oxidative stress and dyslipidaemia
}}
| This area was generated with Dilib version V0.6.33. |  |